Point-of-care testing reduces antibiotic prescribing in acute exacerbations of chronic obstructive pulmonary disease:

Xiying Li1, Shengyue Qiu1, Chaojie Liu2

  • 1School of Public Health, Medical Division, Sun Yat-sen University, Guangzhou, China.

Abstract

Insights

Point-of-care testing (POCT) significantly reduces antibiotic prescriptions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This approach lowers antibiotic use without negatively impacting patient clinical outcomes, aiding antimicrobial resistance efforts.

Area of Science:

  • Pulmonary Medicine
  • Infectious Disease
  • Diagnostic Technologies

Background:

  • Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) present diagnostic challenges, leading to widespread antibiotic overuse.
  • Point-of-care testing (POCT) offers a potential solution for pathogen identification and optimizing antibiotic prescribing.

Purpose of the Study:

  • To systematically review the impact of POCT on antibiotic prescriptions for AECOPD.
  • To evaluate the effects of POCT on both antibiotic-related and clinical outcomes in AECOPD patients.

Main Methods:

  • A systematic review was conducted following a registered protocol (CRD42024555847).
  • Searched for eligible studies evaluating POCT for AECOPD antibiotic guidance.
  • Performed meta-analyses, including subgroup analyses by POCT type and timing, and assessed risk of bias.

Main Results:

  • Included 18 studies with 4346 AECOPD patients.
  • POCT reduced antibiotic prescriptions by 16% (P < 0.001) and duration by 1.19 days (P = 0.04).
  • No adverse effects on clinical outcomes like hospital stay (P = 0.19) were observed; results were robust.

Conclusions:

  • POCT provides evidence for reducing antibiotic exposure in AECOPD without compromising clinical outcomes.
  • Encouraging POCT use is vital for combating antimicrobial resistance through improved diagnostics.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
166
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
135
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K